Showing results (2851-2860 of 5,145) with videos related to
Sort By:
Pageof 515
Vox Sanguinis|January 1, 1991
Antibody removal therapy used successfully at delivery of a pregnant patient with Glanzmann's thrombasthenia and multiple anti-platelet antibodiesK Ito, H Yoshida, H Hatoyama, et al.Vox Sanguinis|January 1, 1991
A new monoclonal anti-A antibody BIRMA-1. A potent culture supernatant which agglutinates Ax cells, but does not give undesirable reactions with B cellsD F McDonald, J M ThompsonVox Sanguinis|January 1, 1991
The in vitro and in vivo evaluation of whole blood and red cell concentrates drawn on CPDA-1 and stored in a non-DEHP plasticized PVC containerS Seidl, W Gosda, A J ReppucciVox Sanguinis|August 18, 2009
Bacterial screening of platelet concentrates: results of 2 years active surveillance of transfused positive cultured units released as negative to dateM M W Koopman, E van't Ende, R Lieshout-Krikke, et al.Vox Sanguinis|August 18, 2009
Microbiology, time course and clinical characteristics of infection in critically ill patients receiving packed red blood cell transfusionJ-S Rachoin, R Daher, C Schorr, et al.Vox Sanguinis|August 12, 2009
Mesenchymal stem cells for clinical applicationL Sensebé, M Krampera, H Schrezenmeier, et al.Vox Sanguinis|July 3, 2009
A pair of naturally occurring antibodies may dampen complement-dependent phagocytosis of red cells with a positive antiglobulin test in healthy blood donorsV Alaia, B M Frey, A Siderow, et al.Vox Sanguinis|July 3, 2009
Simultaneous genotyping of human platelet antigen-1 to 17w by polymerase chain reaction sequence-based typingX Xu, F Zhu, Y Ying, et al.Vox Sanguinis|July 3, 2009
The use of cord blood for transfusion purposes: current statusC M Khodabux, A BrandVox Sanguinis|June 25, 2009
Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLGA Neisser-Svae, A Bailey, L Gregori, et al.Pageof 515